Efficacy and Neuroimaging Mechanisms of Smoking Cessation in China
- Conditions
- Cigarette SmokingSmoking CessationPsychological Interventions
- Interventions
- Behavioral: Cognitive behavior therapy
- Registration Number
- NCT05788068
- Lead Sponsor
- Sir Run Run Shaw Hospital
- Brief Summary
This proposed project is to assess the efficacy of CBT-based digital smoking cessation interventions in China, as well as explore its neuroimaging mechanisms.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 120
- Use cigarettes for no less than 1 year, and use cigarettes ≥ 10 per day
- Nicotine dependence (FTCD ≥ 3)
- Willing to make an attempt to quit smoking in the next month, and have not quit smoking in the past 3 months, and .
- No other addictions except nicotine
- Education level of junior high school or above
- Age between 18 to 45 years old
- Right-handed
- No contraindication of MRI scanning
- Willing to provide informed consent to participate in the study.
- Patients who are receiving medication
- Previous and current mental disorders,and/or mental disorders in line with DSM-5 diagnostic criteria in two departments and three generations.
- Brain organic disease, brain injury history, coma history
- Serious physical disease, endocrine disease history, abnormal blood picture, heart, liver and kidney function after examination
- Pregnant and lactating women
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description Intervention Group Cognitive behavior therapy Participants in the intervention group will receive CBT-based digital smoking cessation intervention. The intervention is a set of smoking cessation methods based on the theoretical study of cognitive behavioral therapy for smoking cessation, and its effectiveness has been confirmed through our large sample of randomized controlled studies. This study plans to intervene smokers for 4 weeks after the start of smoking cessation.
- Primary Outcome Measures
Name Time Method Biochemically Validated Continuously Abstinence 4 weeks Biochemical validation of 4-week continuous smoking abstinence by urine cotinine test.
Brain Structural Characteristics 4 weeks Differences of brain structure between successful and unsuccessful smokers after intervention, which will be measured by white matter volume, gray matter volume, cortical thickness, and surface area.
Brain Functional activity 4 weeks Differences of whole brain function activity between successful and unsuccessful smokers after intervention, which will be measured by ReHo, ALFF, fALFF, and functional connectivity (FC)
- Secondary Outcome Measures
Name Time Method Self-reported 7-day Point Abstinence 4 weeks Self-reported 7-day point-prevalence abstinence at week 1, 4, 8, 12, 16, 20 and 26 after quit date.
Self-reported Continuous Abstinence 4 weeks Self-reported continuous smoking abstinence rate at weeks 4, 8, 12, 16, 20, and 26 after the quit date.
Trial Locations
- Locations (1)
Yanhui Liao
🇨🇳Hanzhou, Zhejiang, China